170 related articles for article (PubMed ID: 21960143)
1. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival.
Kim SJ; Kim KH; Ahn ER; Yoo BC; Kim SY
Amino Acids; 2013 Jan; 44(1):73-80. PubMed ID: 21960143
[TBL] [Abstract][Full Text] [Related]
2. Divergent results induced by different types of septic shock in transglutaminase 2 knockout mice.
Yoo H; Ahn ER; Kim SJ; Lee SH; Oh SH; Kim SY
Amino Acids; 2013 Jan; 44(1):189-97. PubMed ID: 23053022
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia.
Lee J; Kim YS; Choi DH; Bang MS; Han TR; Joh TH; Kim SY
J Biol Chem; 2004 Dec; 279(51):53725-35. PubMed ID: 15471861
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Ku BM; Kim DS; Kim KH; Yoo BC; Kim SH; Gong YD; Kim SY
FASEB J; 2013 Sep; 27(9):3487-95. PubMed ID: 23704086
[TBL] [Abstract][Full Text] [Related]
5. Detection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry.
Grabarek J; Ardelt B; Kunicki J; Darzynkiewicz Z
Cytometry; 2002 Oct; 49(2):83-9. PubMed ID: 12357464
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.
Park KS; Kim DS; Ko C; Lee SJ; Oh SH; Kim SY
Front Biosci (Elite Ed); 2011 Jan; 3(1):341-54. PubMed ID: 21196314
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.
Kim DS; Kim B; Tahk H; Kim DH; Ahn ER; Choi C; Jeon Y; Park SY; Lee H; Oh SH; Kim SY
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):479-84. PubMed ID: 21094133
[TBL] [Abstract][Full Text] [Related]
8. I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Kim DS; Han BG; Park KS; Lee BI; Kim SY; Bae CD
Biochem Biophys Res Commun; 2010 Aug; 399(2):300-6. PubMed ID: 20659425
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
10. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.
Park KS; Han BG; Lee KH; Kim DS; Kim JM; Jeon H; Kim HS; Suh SW; Lee EH; Kim SY; Lee BI
Cancer Lett; 2009 Feb; 274(2):201-7. PubMed ID: 18851895
[TBL] [Abstract][Full Text] [Related]
11. A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Kim JM; Voll RE; Ko C; Kim DS; Park KS; Kim SY
J Mol Biol; 2008 Dec; 384(4):756-65. PubMed ID: 18950638
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
[TBL] [Abstract][Full Text] [Related]
13. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
Hong GU; Park BS; Park JW; Kim SY; Ro JY
Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
[TBL] [Abstract][Full Text] [Related]
14. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Kim DS; Park SS; Nam BH; Kim IH; Kim SY
Cancer Res; 2006 Nov; 66(22):10936-43. PubMed ID: 17108131
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation.
Heinrich M; Neumeyer J; Jakob M; Hallas C; Tchikov V; Winoto-Morbach S; Wickel M; Schneider-Brachert W; Trauzold A; Hethke A; Schütze S
Cell Death Differ; 2004 May; 11(5):550-63. PubMed ID: 14739942
[TBL] [Abstract][Full Text] [Related]
16. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
17. Nuclear translocation of NF-kappaB precedes apoptotic poly(ADP-ribose) polymerase cleavage during productive HSV-1 replication in corneal epithelial cells.
Goodkin ML; Epstein S; Asbell PA; Blaho JA
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4980-8. PubMed ID: 17962448
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
Lee SH; Kim N; Kim SJ; Song J; Gong YD; Kim SY
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1279-94. PubMed ID: 23604466
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.
Kim Y; Eom S; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Kim YM; Ha KS; Ro JY; Jeoung D
Mol Immunol; 2010 Feb; 47(5):1010-22. PubMed ID: 20004474
[TBL] [Abstract][Full Text] [Related]
20. Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
Kim DS; Park KS; Jeong KC; Lee BI; Lee CH; Kim SY
Cancer Lett; 2009 Jan; 273(2):243-9. PubMed ID: 18804908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
